Erudite Pharma SRL
1.6 FTEErudite Pharma reported total assets of €1.40m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 1.6 full-time equivalent.
The score of Erudite Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets -13 % Headcount (avg FTE) -27 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Erudite Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Erudite Pharma's financial analysis
- Solvency24.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Erudite Pharma
Erudite Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0740.537.194
- VAT number
- BE0740537194
- Peppol
- Registered · 0208:0740537194 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Dec 2019
- Registered office
- 8500 Kortrijk
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Erudite Pharma (SRL) has been based in Kortrijk since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 17,585 € and equity of 340,033 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 24.2%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Erudite Pharma
Companies in the same business, of comparable size and area, outside its group.
- Exacare Farma Retail sale of pharmaceutical products Lokeren · balance sheet €1.40m
- Apotheek de Brabandere Oudenaarde Retail sale of pharmaceutical products Oudenaarde · balance sheet €1.41m
- Pharmacie de Barchon Retail sale of pharmaceutical products Blegny · balance sheet €1.41m
- De la Dreve Retail sale of pharmaceutical products Waterloo · balance sheet €1.40m
- Rathaus Apotheke Retail sale of pharmaceutical products Sankt Vith · balance sheet €1.42m
- Apoteek Piqueur Retail sale of pharmaceutical products Kapellen · balance sheet €1.42m
- Sogipharma Retail sale of pharmaceutical products Wavre · balance sheet €1.43m
- Dynamic Pharma Retail sale of pharmaceutical products Arlon · balance sheet €1.43m
Frequently asked questions about Erudite Pharma
What is the revenue of Erudite Pharma?
Erudite Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Erudite Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0740537194 for Erudite Pharma, if the company is VAT-registered. Its company number (CBE) is 0740.537.194.
Where is the registered office of Erudite Pharma?
According to the CBE register, the registered office of Erudite Pharma is in 8500 Kortrijk.
What is the equity of Erudite Pharma?
At the close of the 2025 financial year, the equity of Erudite Pharma amounts to 340,033 €, a solvency of 24.2% of total assets.
How many people work at Erudite Pharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Erudite Pharma?
The register lists 5 active mandates at Erudite Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Erudite Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →